Does Dr. EVERETT VOKES have financial conflicts of interest?

Dr. EVERETT VOKES (MD) has received a total of $82,722 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $67,947 in personal promotional payouts (consulting, meals, travel) and $14,775 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. EVERETT VOKES?

According to CMS Open Payments data, Dr. EVERETT VOKES received funding from BIONTECH SE ($38,353), BOEHRINGER INGELHEIM INTERNATIONAL ($11,875), and GENMAB U.S ($6,140).

Does Dr. EVERETT VOKES receive research grants or speaking fees?

Dr. EVERETT VOKES has received $67,947 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $14,775 in clinical research grants.

DR. EVERETT VOKES

MDReal-Time Hydrated

Specialty: Internal Medicine, Medical Oncology

Practice Location: CHICAGO, IL 60637

NPI Number: 1932262458

LIFETIME INDUSTRY VALUE

$82,722

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. VOKES is a verified Internal Medicine, Medical Oncology practitioner based in CHICAGO, IL.

Between 2021 and 2025, Dr. VOKES had an overall industry promotional and research financial footprint of $82,722 as recorded in the federal CMS Open Payments database.

$67,947 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$14,775 was allocated to sponsored clinical trials and medical research activities.

Dr. VOKES's primary funding source is BIONTECH SE, which accounts for $38,353 (representing 46.4% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BIONTECH SE

Rank 1

$38,353

46.4%

BOEHRINGER INGELHEIM INTERNATIONAL

Rank 2

$11,875

14.4%

GENMAB U.S

Rank 3

$6,140

7.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.